Medical innovation and discovery improves patient care, advances scientific knowledge, prevents and treats disease, and strengthens our economy through collaborations between medical centers and private industry. To fulfill our mission of advancing patient care through research, our obstetrics and gynecology faculty are at the forefront of medical discovery.
A number of
multi-center clinical trials are available to gynecologic cancer patients which may allow them access to new and promising therapies.
A breakthrough in the prevention of cervical cancer came recently when
UW researchers laid the foundation for a vaccine against human papilloma virus (HPV), which is the cause of the majority of cervical cancers and genital warts. Over the past dozen years, UW researchers have studied many aspects of HPV, from its spread to its detection, its natural history inside the body and its role in cancer.
UW School of Public Health and Community medicine epidemiologist Dr. Laura Koutsky helped lead a study of the effectiveness of the HPV vaccine in preventing cancer. The findings led to recent FDA approval of Gardasil, the first vaccine shown to prevent cervical cancer, precancerous genital lesions and genital warts due to HPV. Koutsky predicted it will make a huge difference in cervical cancer rates in the next couple of decades. Her collaborator,
Dr. Connie Mao, a UW assistant professor of obstetrics and gynecology, believes the vaccine will be especially important for women who live in countries with scarce medical resources.